Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
Location: United States, Colorado, Boulder
Member count: 1-10
Total raised: $20.2M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | Fifty Year... | fiftyyears... |
| 21.07.2020 | Y Combinat... | ycombinato... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 07.09.2022 | Series A | $17M | - | finsmes.co... |
| 15.01.2020 | Seed | $3.2M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 07.09.2022 | Arpeggio B... | How can drug developers design... | - | - | medcitynew... |
| 07.09.2022 | Arpeggio B... | Arpeggio Biosciences, a Boulde... | USA | - | finsmes.co... |
| 15.01.2020 | Arpeggio B... | Arpeggio Bio , a Boulder, Colo... | USA | - | finsmes.co... |